Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement
Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement
复制标题
DOI：
10.7326/0003-4819-144-5-200603070-00013
复制
发表时间：
2006-03-07
影响因子：
39.2
通讯作者：
Bombardier, C
中科院分区：
文献类型：
--
作者：
Gagnier, JJ;Boon, H;Bombardier, C
草药产品应用广泛，含量和质量差异很大，并在随机对照试验(RCT)中进行积极测试。作者的目标是基于详细说明22项COSORT(报告试验的综合标准)核对表的需要，制定报告草药干预的随机对照试验的建议。在加拿大多伦多举行了电话会议，并与16名与会者举行了协商一致会议，以制定这些建议。工作组商定了关于草药随机对照试验的9个联合清单项目的具体情况。关于草药干预的项目4需要作最广泛的阐述。制定这些建议是为了改进使用草药干预的随机对照试验的报告。
Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item CONSORT (Consolidated Standards of Reporting Trials) checklist. Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations. The group agreed on context-specific elaborations of 9 CONSORT checklist items for RCTs of herbal medicines. Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.